Team Challenge, the charitable arm of the Crohn's & Colitis Foundation of America, will send a small, yet mighty team of walkers and runners to Las Vegas this November to participate in the Rock & Roll Half Marathon in order to raise awareness of and money for research to end Crohn's Disease and Colitis of all forms.
Rock & Roll for Rock & Roll is just that: a rock and roll benefit concert to help this team reach their fund raising goals in order to attend this national event.
$20 in advance or at the door gets you access to dinner, drinks, a chance for exciting raffle prizes, and live music.
Classic Rock cover band III Day Weekend is booked to rock the night away for your singing, dancing, and listening pleasure.
Raffle prizes include a football signed by Baltimore Ravens Quarterback Joe Flacco, a Baltimore Blast package including 4 tickets to a Baltimore Blast game and a soccer ball signed by the team, and gift cards to local bars, restaurants, and businesses.
Please contact email@example.com for more information, to make a donation, or to purchase tickets.
All proceeds will benefit the Crohn's & Colitis Foundation of America.
The Crohn's and Colitis Foundation of America (CCFA) is a non-profit, volunteer-driven organization dedicated to finding the cures for Crohn's Disease and ulcerative colitis. It was founded in 1967 by Irwin M. and Suzanne Rosenthal, William D. and Shelby Modell, and Henry D. Janowitz, M.D.
Since their founding over four decades ago, CCFA has remained at the forefront of research in Crohn's disease and ulcerative colitis. Today, CCFA funds cutting-edge studies at major medical institutions, nurture investigators at the early stages of their careers, and finance underdeveloped areas of research. In additio, their educational workshops and programs, along with their scientific journal, Inflammatory Bowel Diseases, enable medical professionals to keep pace with this rapidly growing field. CCFA is very proud that the National Institutes of Health has commended them for "uniting the research community and strengthening IBD research."